BioRestorative Therapies BRTX
NASDAQ BRTX
$2.20 -0.07 (-3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioRestorative Therapies (BRTX) Return on Capital Employed [ROCE] (2020 - 2025)

Updated

BioRestorative Therapies' Return on Capital Employed [ROCE] came in at -1374.66% for Q4 2025, down 1255.26 percentage points from -119.39% a year earlier and down 976.41 percentage points from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Return on Capital Employed [ROCE] (2020 - 2025) Analysis & Trends

For FY2025, BioRestorative Therapies' Return on Capital Employed [ROCE] was -351.08%, down 218.22 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -203.27 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -132.86% in FY2024 (-5.12 pp), -127.74% in FY2023 (+13.21 pp), -140.94% in FY2022 (+60.86 pp) and -201.80% in FY2021 (-53.99 pp).
  • The Q4 2025 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q3 2021.
  • Year-over-year, Return on Capital Employed [ROCE] has declined for four consecutive quarters, with an average year-over-year change of -129.23 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2021 (a gain of 1363.25 percentage points), and the weakest in Q4 2025 (a drop of 1255.26 percentage points).
  • Business Quant data shows BRTX's Return on Capital Employed [ROCE] at -398.25% (Q3 2025), -227.63% (Q2 2025) and -172.07% (Q1 2025) in the three quarters before Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 BioRestorative Therapies 976,386.42 -22.96 Mn 17,964.00 -1,374.66%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1,374.66%
Sep 30, 2025 -398.25%
Jun 30, 2025 -227.63%
Mar 31, 2025 -172.07%
Dec 31, 2024 -119.39%
Sep 30, 2024 -112.27%
Jun 30, 2024 -110.14%
Mar 31, 2024 -114.51%
Dec 31, 2023 -143.60%
Sep 30, 2023 -158.08%
Jun 30, 2023 -583.14%
Mar 31, 2023 -253.94%
Dec 31, 2022 -169.48%
Sep 30, 2022 -170.36%
Jun 30, 2022 -132.39%
Mar 31, 2022 -233.39%
Dec 31, 2021 -220.14%
Sep 30, 2021 -1,397.74%
Jun 30, 2021 -1,020.77%
Mar 31, 2021 -621.46%
API Access

BioRestorative Therapies Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BRTX&period=max&api_key=YOUR_API_KEY